Data as of Jan 30
| -0.47 / -0.35%|
The 15 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 139.00, with a high estimate of 160.00 and a low estimate of 95.00. The median estimate represents a +3.22% increase from the last price of 134.67.
The current consensus among 19 polled investment analysts is to Hold stock in Salix Pharmaceuticals Ltd. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.